Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inna Gordiienko

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Plos One|April 26, 2024
The KRAS, ATR and CHEK1 expression levels in endometrial cancer are the risk factors predicting recurrenceLiubov Buchynska, Inna Gordiienko, Nadiia Glushchenko, et al.
Clinical Immunology (Orlando, Fla.)|January 9, 2019
SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?Inna Gordiienko, Larysa Shlapatska, Larysa Kovalevska, et al.
Neoplasma|April 27, 2021
CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cellsValeriia Shcherbina, Inna Gordiienko, Larysa Shlapatska, et al.
Thescientificworldjournal|December 7, 2018
<i>In Vitro</i> Study of Deuterium Effect on Biological Properties of Human Cultured Adipose-Derived Stem CellsAlona Zlatska, Inna Gordiienko, Roman Vasyliev, et al.
Plos One|October 6, 2017
The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signalingInna Gordiienko, Larysa Shlapatska, Valeriia Kholodniuk, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Plos One|April 26, 2024
The KRAS, ATR and CHEK1 expression levels in endometrial cancer are the risk factors predicting recurrenceLiubov Buchynska, Inna Gordiienko, Nadiia Glushchenko, et al.
Clinical Immunology (Orlando, Fla.)|January 9, 2019
SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?Inna Gordiienko, Larysa Shlapatska, Larysa Kovalevska, et al.
Neoplasma|April 27, 2021
CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cellsValeriia Shcherbina, Inna Gordiienko, Larysa Shlapatska, et al.
Thescientificworldjournal|December 7, 2018
<i>In Vitro</i> Study of Deuterium Effect on Biological Properties of Human Cultured Adipose-Derived Stem CellsAlona Zlatska, Inna Gordiienko, Roman Vasyliev, et al.
Plos One|October 6, 2017
The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signalingInna Gordiienko, Larysa Shlapatska, Valeriia Kholodniuk, et al.
Pageof 1